摘要
目的探究痰热清联合蚕食清创术治疗糖尿病性足病的应用价值。方法选取2015年8月至2021年12月衡水市第四人民医院接受治疗的1100例糖尿病足患者作为研究对象,按照奇偶数随机分组法分为参照组和观察组,每组550例,参照组单纯采用蚕食清创术治疗,并给予患者常规护理工作;观察组在参照组基础上联合痰热清注射液治疗。以临床治疗指标、经济价值、临床疗效、创面分泌物、复发率等指标评估。结果观察组患者创面愈合时间、抗生素使用时间、住院时间、换药次数均少于参照组,差异有统计学意义(P<0.05);观察组患者临床疗效高于参照组,复发率低于参照组,差异有统计学意义(P<0.05);观察组患者创面分泌物培养阳性率低于参照组,差异有统计学意义(P<0.05);观察组患者经济价值高于参照组,观察组患者经济费用节省19.5%。结论在糖尿病性足病创面修复中,采用痰热清联合蚕食清创术治疗方案具有较高的经济价值,临床效果显著,加快患者创面愈合速度,降低复发率,减少患者抗生素类药物使用,保障患者健康。
Objective To explore the effect of Tanreqing combined with nibbling debridement on wound healing in patients with diabetic foot,and understand its economic cost.Methods From August 2015 to December 2021,a total of 1100 patients with diabetic foot visited in the No.4 People’s Hospital of Hengshui were selected as the research objects,and they were divided into the reference group and the observation group by parity number.All patients were managed with nibbling debridement and conventional care,those in the observation group were additionally treated with Tanreqing injection.The treatment indicators,economic value,clinical efficacy,wound secretions,recurrence rate were evaluated between groups.Results The wound healing time,antibiotic use time,hospitalization time,and dressing change times in the observation group were significantly better than those in the reference group(P<0.05).The clinical efficacy in the observation group was significantly higher than that of the reference group,but the recurrence rate was significantly lower(P<0.05).The positive rate of wound secretion culture in the observation group was significantly lower than that in the reference group(P<0.05);the economic cost of the observation group was higher than the reference group,cost savings of 19.5%versus the observation group.Conclusion Tanreqing combined with nibbling debridement has a high economic value in the wound repair of diabetic foot disease,which has significant clinical effect,can accelerate the wound healing speed,reduce the recurrence rate and the use of antibiotics,and protect the health of patients.
作者
宋文菊
杜新芝
张辉
杜新曼
SONG Wenju;DU Xinzhi;ZHANG Hui(The No.4 People’s Hospital of Hengshui,Hebei,Hengshui 053000,China)
出处
《河北医药》
CAS
2024年第10期1552-1555,共4页
Hebei Medical Journal